Fig. 3From: An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020A proposed mechanism for the anthracycline-trastuzumab interaction. The repair of vulnerable myocytes is impeded by trastuzumab, furthering the pathway toward cell death [1]Back to article page